Literature DB >> 16299040

Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1.

Y Motomura1, W I Khan, R T El-Sharkawy, M Verma-Gandhu, E F Verdu, J Gauldie, S M Collins.   

Abstract

BACKGROUND AND AIMS: Monocyte chemoattractant protein 1 (MCP-1) is increased transmurally in inflammatory bowel disease (IBD). Although MCP-1 is considered to play an important role in fibrotic disease in other organs, the role of MCP-1 in gut fibrosis is unknown. We investigated the fibrotic potential of MCP-1 in the gut by overexpressing this chemokine in the mouse colorectal wall.
METHODS: Intramural gene transfer by direct injection of adenovector into the mouse rectal wall was established. C57BL/6 and Rag2(-/-) (B and T cell deficient) mice received 2.5 x 10(9) plaque forming units of an adenovector encoding murine MCP-1 (AdMCP-1) or control virus (AdDL70) via intramural injection. Mice were killed at various time points and tissues were obtained for histopathological and biochemical analysis.
RESULTS: AdMCP-1 significantly increased collagen production in the colorectum and this was associated with significant elevation of transforming growth factor beta (TGF-beta) and tissue inhibitor of metalloproteinase (TIMP-1) protein. Transmural collagen deposition was observed after AdMCP-1 administration, and was accompanied by CD3+ T cells, F4/80+ macrophages, and vimentin+ cell infiltrates. Collagen was differentially distributed, with type I deposited in the muscularis mucosa and muscularis propria and type III in the submucosa and myenteric plexus. AdMCP-1 failed to induce collagen overproduction in immunodeficient Rag2(-/-) mice.
CONCLUSION: These findings suggest that MCP-1 can induce fibrosis in the gut and that this process involves interaction between T cells and vimentin positive fibroblasts/myofibroblasts, as well as the subsequent upregulation of TGF-beta and TIMP-1 production. This model provides a basis for considering MCP-1 in the pathogenesis of strictures in IBD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299040      PMCID: PMC1856110          DOI: 10.1136/gut.2005.068429

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

1.  The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats.

Authors:  Masanobu Inoue; Yoshifumi Ino; Junya Gibo; Tetsuhide Ito; Terumasa Hisano; Yoshiyuki Arita; Hajime Nawata
Journal:  Pancreas       Date:  2002-11       Impact factor: 3.327

2.  Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis.

Authors:  Jesús Rivera-Nieves; Giorgos Bamias; Alda Vidrich; Marco Marini; Theresa T Pizarro; Marcia J McDuffie; Christopher A Moskaluk; Steven M Cohn; Fabio Cominelli
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

3.  Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease.

Authors:  A Stallmach; D Schuppan; H H Riese; H Matthes; E O Riecken
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

4.  Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3.

Authors:  O Eickelberg; E Köhler; F Reichenberger; S Bertschin; T Woodtli; P Erne; A P Perruchoud; M Roth
Journal:  Am J Physiol       Date:  1999-05

5.  Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts.

Authors:  E A van Tol; L Holt; F L Li; F M Kong; R Rippe; M Yamauchi; J Pucilowska; P K Lund; R B Sartor
Journal:  Am J Physiol       Date:  1999-07

Review 6.  Human monocyte chemoattractant protein-1 (MCP-1).

Authors:  E J Leonard; T Yoshimura
Journal:  Immunol Today       Date:  1990-03

7.  A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B.

Authors:  Ian C Lawrance; Feng Wu; André Z A Leite; Joseph Willis; Gail A West; Claudio Fiocchi; Shukti Chakravarti
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

Review 8.  Medical therapy for Crohn's disease strictures.

Authors:  Gert Van Assche; Karel Geboes; Paul Rutgeerts
Journal:  Inflamm Bowel Dis       Date:  2004-01       Impact factor: 5.325

9.  Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease.

Authors:  L Mazzucchelli; C Hauser; K Zgraggen; H E Wagner; M W Hess; J A Laissue; C Mueller
Journal:  J Pathol       Date:  1996-02       Impact factor: 7.996

10.  Blockade of CCR2 ameliorates progressive fibrosis in kidney.

Authors:  Kiyoki Kitagawa; Takashi Wada; Kengo Furuichi; Hiroyuki Hashimoto; Yoshiro Ishiwata; Masahide Asano; Motohiro Takeya; William A Kuziel; Kouji Matsushima; Naofumi Mukaida; Hitoshi Yokoyama
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

View more
  15 in total

1.  Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection.

Authors:  Daniela Damjanovic; Maziar Divangahi; Kapilan Kugathasan; Cherrie-Lee Small; Anna Zganiacz; Earl G Brown; Cory M Hogaboam; Jack Gauldie; Zhou Xing
Journal:  Am J Pathol       Date:  2011-10-14       Impact factor: 4.307

Review 2.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 3.  Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.

Authors:  Florian Rieder; Sean Kessler; Miquel Sans; Claudio Fiocchi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-09       Impact factor: 4.052

4.  Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis.

Authors:  Anthie Yiakouvaki; Marios Dimitriou; Ioannis Karakasiliotis; Christina Eftychi; Stamatis Theocharis; Dimitris L Kontoyiannis
Journal:  J Clin Invest       Date:  2011-12-27       Impact factor: 14.808

5.  SHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosis.

Authors:  Keith W McLarren; Alexandra E Cole; Shelley B Weisser; Nicole S Voglmaier; Victoria S Conlin; Kevan Jacobson; Oana Popescu; Jean-Luc Boucher; Laura M Sly
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

6.  Substance P modulates colitis-associated fibrosis.

Authors:  Hon Wai Koon; David Shih; Iordanes Karagiannides; Dezheng Zhao; Zafeer Fazelbhoy; Tressia Hing; Hua Xu; Bao Lu; Norma Gerard; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

7.  Irsogladine maleate ameliorates inflammation and fibrosis in mice with chronic colitis induced by dextran sulfate sodium.

Authors:  Hana Yamaguchi; Kenji Suzuki; Masaki Nagata; Tomoyuki Kawase; Vijayakumar Sukumaran; Rajarajan A Thandavarayan; Yusuke Kawauchi; Junji Yokoyama; Masayuki Tomita; Hiroshi Kawachi; Kenichi Watanabe; Hiroyuki Yoneyama; Hitoshi Asakura; Ritsuo Takagi
Journal:  Med Mol Morphol       Date:  2012-09-22       Impact factor: 2.309

Review 8.  Intestinal fibrosis in IBD--a dynamic, multifactorial process.

Authors:  Florian Rieder; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

9.  Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-induced tubulointerstitial nephritis mouse model.

Authors:  Mizuho Tamura; Reiko Aizawa; Masatoshi Hori; Hiroshi Ozaki
Journal:  Histochem Cell Biol       Date:  2009-01-22       Impact factor: 4.304

Review 10.  The gut microbiome in intestinal fibrosis: environmental protector or provocateur?

Authors:  Florian Rieder
Journal:  Sci Transl Med       Date:  2013-06-19       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.